ESC & iPSC News Volume 5.42 | Oct 27 2010

    0
    60
    ESC & iPSC News 5.42, October 27, 2010.
    In this issue:  Science News |  Current Publications |  Industry News |  Policy News |  Events
    Subscribe  |  Unsubscribe


    TOP STORY

    SIRT1 Deficiency Compromises Mouse Embryonic Stem Cell Hematopoietic Differentiation, and Embryonic and Adult Hematopoiesis in the Mouse 
    Researchers examined hematopoietic and endothelial cell differentiation of SIRT1-/- mouse embryonic stem cells in vitro, and hematopoietic progenitors in SIRT1+/+, +/-, and -/- mice. [Blood]

    Defining Characteristics of Bona Fide Human iPS Cells
    Speaker: Sutheera Ratanasirintrawoot, PhD Candidate
    G. Daley & T. Schlaeger Labs, Harvard Medical School
    WEBINAR: VIEW HERESTEMCELL Technologies Inc


    SPECIAL FEATURE

    Interested in recruiting talented individuals? Post your career opportunities in ESC & iPSC News at no cost. Contact us at info@connexoncreative.com

    Follow us on Twitter! @ESC_iPSC_News

    SCIENCE NEWS

    New High-Content Assay to Increase Human Embryonic Stem Cell Survival
    Researchers from the Universities of Dundee, Glasgow and Heriot-Watt University, Edinburgh, have produced a high-content assay for human embryonic stem cell survival and used this to screen a range of libraries of ‘lead-like’ small molecules and known bioactives. [Press release from The Medical News discussing online prepublication in the Biochemical Journal]
     
    Bioelectrical Signals Turn Stem Cells’ Progeny Cancerous
    Biologists have discovered that a change in membrane voltage in newly identified “instructor cells” can cause stem cells’ descendants to trigger melanoma-like growth in pigment cells. The team also found that this metastatic transformation is due to changes in serotonin transport. [Press release from Tufts University discussing online prepublication in Disease Models and Mechanisms]
     
    Scientists Create Australia’s First Diabetes Cells
    In a major research advance, Melbourne researchers have created Australia’s first type 1 diabetes cells. Researchers created the diabetes cells using induced pluripotent stem cell technology. [Monash Institute of Medical Research Press Release]

    STEMcircles_645x110

    CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)

    Integrated Biochemical and Mechanical Signals Regulate Multifaceted Human Embryonic Stem Cell Functions
    Feedback regulation and mechanical-biochemical integration provide mechanistic insights for the regulation of intercellular adhesion and cellular architecture in embryonic stem cells during long-term self-renewal. [J Cell Biol]
     
    Genome-Wide Identification of Targets and Function of Individual MicroRNAs in Mouse Embryonic Stem Cells
    Data suggest that miR-294 may promote pluripotency by regulating a subset of c-Myc target genes and upregulating pluripotency-associated genes such as Lin28. [PLoS Genet]

    Production of Functional Glucagon-Secreting Alpha Cells from Human Embryonic Stem Cells
    Results indicate that fully differentiated pancreatic endocrine cells can be created via step-wise differentiation of human embryonic stem cells. [Diabetes]

    Somatic Cell Nuclear Reprogramming of Mouse Oocytes Endures Beyond Reproductive Decline
    Researchers show that oocytes isolated from mice aged beyond the usual reproductive age yield ooplasts that retain reprogramming capacity after somatic nuclear transfer, giving rise to higher blastocysts rates compared to young donors ooplasts. [Aging Cell]
     
    High-Content Screening of Feeder-Free Human Embryonic Stem Cells to Identify Pro-Survival Small Molecules
    Researchers have developed a high-content assay for human embryonic stem cell survival and used this to screen a range of libraries of ‘lead-like’ small molecules and known bioactives. [Biochem J]
     
    Human Pluripotent Stem Cells Produce Natural Killer Cells That Mediate Anti-HIV-1 Activity Utilizing Diverse Cellular Mechanisms
    Researchers demonstrate derivation of functional natural killer (NK) cells from human induced pluripotent stem cells (iPSCs). More importantly, both human embryonic stem cell- and iPSC-derived NK cells are able to inhibit HIV-1 NL4-3 infection of CEM-GFP cells. [J Virol]

    Nanofiber Matrices Promote the Neuronal Differentiation of Human Embryonic Stem Cell Derived-Neural Precursors In Vitro
    Researchers cultured human neural precursors (NPs) derived from the NIH-approved embryonic stem line BGO1 on polycaprolactone fiber matrices of different diameter (i.e. nanofibers and microfibers) and orientation (i.e. aligned and random); fibers were coated with poly-L-ornithine/laminin to mimic the extracellular matrix and support the adhesion, viability and differentiation of NPs. [Tissue Eng Part A]
     
    Transmembrane Potential of GlyCl-Expressing Instructor Cells Induces a Neoplastic-Like Conversion of Melanocytes via a Serotonergic Pathway
    Data reveal glycine receptor chloride channel (GlyCl) as a molecular marker of a sparse and heretofore unknown cell population with the ability to specifically instruct neural crest derivatives, suggest transmembrane potential as a tractable signaling modality by which somatic cells can control stem cell behavior at considerable distance, identify a new biophysical aspect of the environment that confers a neoplastic-like phenotype upon stem cell progeny, reveal a pre-neural role for serotonin and its transporter, and suggest a novel strategy for manipulating stem cell behavior. [Dis Models Mech]

    Enhanced Reprogramming and Cardiac Differentiation of Human Keratinocytes Derived from Plucked Hair Follicles, Using a Single Excisable Lentivirus
    Researchers describe a detailed and reproducible method to derive induced pluripotent stem cells (iPSCs) from plucked human hair follicle keratinocytes. All emerging colonies were true iPSCs, with characteristics typical of human embryonic stem cells, differentiated into derivatives of all three germ layers in vitro and in vivo. [Cell Reprogram]

    INDUSTRY NEWS

    Cellectis and the Center for iPS Cells Research and Application Enter Collaboration
    Cellectis and the Center for iPS Cells Research and Application (CiRA) of Kyoto University have announced that they have started a scientific collaboration to combine Cellectis’ genome engineering technologies with CiRA’s induced pluripotent stem cell (iPS) technology to improve the natural characteristics of iPS cells for use as cellular tools. [Cellectis Press Release]

    Sanofi-aventis Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of Genzyme
    Sanofi-aventis announced that the waiting period under the Hart-Scott Rodino Antitrust Improvements Act of 1976, as amended, applicable to Sanofi-aventis’ proposed acquisition of Genzyme Corporation has expired. [Sanofi-aventis Press Release]

    CIRM Funds $72 Million to Translate Basic Discoveries into New Therapies, Recruit Stem Cell Leaders to California
    The California Institute for Regenerative Medicine (CIRM) approved funding for 19 awards worth $67 million in its second round of awards designed to move good ideas out of the lab and into the clinic. [The California Institute for Regenerative Medicine Press Release]
     
    Over 400 Top Researchers Selected in the European Research Council’s Third Prestigious ‘Starting Grant’ Competition
    The European Research Council is awarding some EUR 580 million to 427 early career top researchers in its competition for ‘Starting Grants’. Worth up to EUR 2 million each, the grants will enable them to carry out their pioneering ideas in any field of research, throughout Europe. [European Research Council, European Union]

    Combining Stem Cell and Gene Therapy Techniques to Tackle a Deadly Blood Disease
    The National Institutes of Health has awarded a three-year, $3.9 million grant to Children’s Hospital Boston researchers and their colleagues to develop a therapy to treat Fanconi anemia. [Children’s Hospital Boston Press Release]
     
    Stem Cell Central: The Lorry I. Lokey Building
    The Lokey Building, an incredible new laboratory facility, is built on a design championed by faculty to facilitate research in one of the most exciting interdisciplinary areas of the 21st century — stem cell biology and regenerative medicine. [Stanford University School of Medicine Press Release]

    POLICY NEWS

    NIH Supporters Line Up to File Legal Stem Cell Arguments
    Numerous friends of human embryonic stem cell research are lining up to support the National Institutes of Health (NIH) in a major court case challenging the agency’s ability to fund the research. [National Institutes of Health, United States]
     
    NIH Recovery Act Grants to Foster Scientific Workforce Diversity
    The National Institutes of Health (NIH) has awarded six grants totaling approximately $12 million over three years through a new initiative aimed at fostering a diverse scientific workforce. [National Institutes of Health, United States]
     
    NIH Recovery Act Awards Enable Crucial Health Research Technologies
    Thanks to the Recovery Act, more health scientists now will have access to state-of-the-art devices, the National Institutes of Health (NIH) announced. Through its National Center for Research Resources, NIH has awarded $300 million in shared instrumentation grants. [National Institutes of Health, United States]

    White House Science Office Sued Over ‘Scientific Integrity’ Docs
    Public Employees for Environmental Responsibility has filed a lawsuit seeking an explanation for why the Obama Administration is 18 months late on delivering its promised guidelines on scientific integrity for the federal government. [Public Employees for Environmental Responsibility, United States]

    Just a Flesh Wound? U.K. Science Budget Spared Deep Cuts
    The U.K. government’s long-awaited Comprehensive Spending Review was released, and it calls for a flat science budget over the next 4 years. While inflationary costs mean that the budget will likely see a cut of about 10% in real terms over that period, this scenario is far less dramatic than rumored cuts of 20% to 30% in real cash. [HM Treasury, United Kingdom]
     
    Cellular, Tissue and Gene Therapies Advisory Committee; Notice of Meeting [Docket No. FDA-2010-N-0001] [Food and Drug Administration, United States]
     
    Guidelines for Use of Stored Specimens and Access to Ancillary Data and Proposed Cost Schedule: Stored Biologic Specimens and Ancillary Data From the Collaborative Perinatal Project (CPP) (FR Doc. 2010-27183) [National Institutes of Health, United States]

    Center for Scientific Review; Notice of Closed Meetings (FR Doc. 2010-27192) [National Institutes of Health, United States]

    Center for Scientific Review; Notice of Closed Meetings (FR Doc. 2010-27185) [National Institutes of Health, United States]

    Center for Scientific Review; Notice of Closed Meetings (FR Doc. 2010-27049) [National Institutes of Health, United States]
     
    Center for Scientific Review; Notice of Closed Meeting (FR Doc. 2010-27040) [National Institutes of Health, United States]

    Center for Scientific Review; Notice of Closed Meeting (FR Doc. 2010-27039) [National Institutes of Health, United States]
     
    Center for Scientific Review; Notice of Closed Meeting (FR Doc. 2010-26935) [National Institutes of Health, United States]

    Center for Scientific Review; Notice of Closed Meetings (FR Doc. 2010-26881) [National Institutes of Health, United States]

    Center for Scientific Review; Notice of Closed Meetings (FR Doc. 2010-26499) [National Institutes of Health, United States]
     
    Center for Scientific Review; Notice of Closed Meetings (FR Doc. 2010-26497) [National Institutes of Health, United States]

    Office of the Director, National Institutes of Health; Notice of Meeting (FR Doc. 2010-27187) [National Institutes of Health, United States]

    EVENTS

    Fraunhofer Life Science Symposium Leipzig 2010
    October 29-30, 2010
    Leipzig, Germany

    5th UK Cancer Stem Cell Symposium
    November 2, 2010
    London, United Kingdom

    BioMalaysia 2010 Conference and Exhibition
    November 1-3, 2010
    Kuala Lumpur, Malaysia

    Stem Cell Society Singapore Symposium 2010: Translating Science to Therapy
    November 2-3, 2010
    Singapore

    NEW In Vitro Toxicology Society Annual Meeting
    November 2-3, 2010
    Liverpool, United Kingdom

    NEW Third Annual Research Experience of Stem Cells in European (RESCUE) Society Conference
    November 8-9, 2010
    Oxford, United Kingdom

    Select Biosciences 2nd International Forum on Stem Cells (2010 IFSC)
    November 12-13, 2010
    Tianjin, China

    The 16th International Conference of the International Society of Differentiation: From Stem Cells to Organisms
    November 15-18, 2010
    Nara, Japan

    8th Annual Commercial Translation of Regenerative Medicine Conference
    November 18-19, 2010
    London, United Kingdom

    Stem Cell Network’s 10th Annual Scientific Meeting
    November 22-24, 2010
    Calgary, Canada

    Tissue Engineering & Regenerative Medicine International Society – North America (TERMIS-NA) 2010 Annual Conference
    December 5-8, 2010
    Orlando, United States

    5th Annual Stem Cell Meeting on the Mesa
    December 7, 2010
    La Jolla, United States

    NEW Pharmacology in Stem Cells Research and Regenerative Medicine
    December 17, 2010
    London, United Kingdom

    Biotech Showcase 2011
    January 10-12, 2011
    San Francisco, United States

    Select Biosciences 5th Annual Stem Cells and Regenerative Medicine World Congress
    January 24-25, 2011
    San Diego, United States

    Keystone Symposia-Stem Cells in Development, Tissue Homeostasis and Disease
    January 30-February 4, 2011
    Santa Fe, United States

    Molecular Medicine Tri-Conference – Stem Cells: Revolutionizing Regenerative Medicine and Personalized Therapy 2011
    February 23-25, 2011
    San Francisco, United States

    American Association for Cancer Research (AACR) Stem Cells, Development, and Cancer
    March 3-6, 2011
    Vancouver, Canada

    Stem Cells, Cancer and Metastasis (C4)
    March 6-11, 2011
    Dillon, United States

    NEW United Kingdom National Stem Cell Network 2011 Annual Scientific Conference
    March 30-April 1, 2011
    York, United Kingdom

    Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.



    JOB OPPORTUNITIES


    Lab Technologist — Human Embryonic and Induced Pluripotent Stem Cells (STEMCELL Technologies)

    Lab Technologist — Tissue Culture (STEMCELL Technologies)

    Product Manager — Pluripotent Stem Cells (STEMCELL Technologies)

    Recruit Top Talent

    Reach more than 11,000 potential candidates by posting your organization’s career opportunities with ESC & iPSC News at no cost.

    Visit here to post your career opportunities.


     

     Learn more about ESC & iPSC News:  Archives |  Events |  Subscribe |  Contact Us